nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCB1—esophageal cancer	0.393	1	CbGaD
Atazanavir—SLCO1B3—Methotrexate—esophageal cancer	0.146	0.344	CbGbCtD
Atazanavir—ABCC1—Methotrexate—esophageal cancer	0.101	0.238	CbGbCtD
Atazanavir—CYP2C9—Capecitabine—esophageal cancer	0.0767	0.181	CbGbCtD
Atazanavir—CYP2C9—Cisplatin—esophageal cancer	0.0386	0.0911	CbGbCtD
Atazanavir—ABCB1—Cisplatin—esophageal cancer	0.0375	0.0884	CbGbCtD
Atazanavir—ABCB1—Methotrexate—esophageal cancer	0.0243	0.0574	CbGbCtD
Atazanavir—Ritonavir—ABCC2—esophageal cancer	0.00187	0.352	CrCbGaD
Atazanavir—Saquinavir—ABCC2—esophageal cancer	0.00142	0.267	CrCbGaD
Atazanavir—Lopinavir—ABCB1—esophageal cancer	0.000819	0.154	CrCbGaD
Atazanavir—Proteinuria—Capecitabine—esophageal cancer	0.000724	0.00636	CcSEcCtD
Atazanavir—Protein urine present—Capecitabine—esophageal cancer	0.000714	0.00627	CcSEcCtD
Atazanavir—Polyuria—Cisplatin—esophageal cancer	0.000714	0.00627	CcSEcCtD
Atazanavir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.0007	0.00615	CcSEcCtD
Atazanavir—Cellulitis—Capecitabine—esophageal cancer	0.0007	0.00615	CcSEcCtD
Atazanavir—Oropharyngeal pain—Capecitabine—esophageal cancer	0.0007	0.00615	CcSEcCtD
Atazanavir—Ritonavir—ABCB1—esophageal cancer	0.000688	0.129	CrCbGaD
Atazanavir—Nasal congestion—Cisplatin—esophageal cancer	0.000688	0.00604	CcSEcCtD
Atazanavir—Burning sensation—Methotrexate—esophageal cancer	0.000682	0.00599	CcSEcCtD
Atazanavir—Blood bilirubin increased—Capecitabine—esophageal cancer	0.000673	0.00591	CcSEcCtD
Atazanavir—Amnesia—Cisplatin—esophageal cancer	0.000667	0.00586	CcSEcCtD
Atazanavir—Bone pain—Capecitabine—esophageal cancer	0.000664	0.00583	CcSEcCtD
Atazanavir—Inflammation—Capecitabine—esophageal cancer	0.000656	0.00576	CcSEcCtD
Atazanavir—Gait disturbance—Capecitabine—esophageal cancer	0.000652	0.00573	CcSEcCtD
Atazanavir—Hiccups—Capecitabine—esophageal cancer	0.000636	0.00559	CcSEcCtD
Atazanavir—Colitis—Capecitabine—esophageal cancer	0.000611	0.00537	CcSEcCtD
Atazanavir—Fluid retention—Capecitabine—esophageal cancer	0.000604	0.00531	CcSEcCtD
Atazanavir—Dehydration—Cisplatin—esophageal cancer	0.000583	0.00512	CcSEcCtD
Atazanavir—Oesophagitis—Capecitabine—esophageal cancer	0.000581	0.00511	CcSEcCtD
Atazanavir—Urine output increased—Capecitabine—esophageal cancer	0.000575	0.00505	CcSEcCtD
Atazanavir—Mouth ulceration—Capecitabine—esophageal cancer	0.000575	0.00505	CcSEcCtD
Atazanavir—Ecchymosis—Capecitabine—esophageal cancer	0.000575	0.00505	CcSEcCtD
Atazanavir—Breast disorder—Cisplatin—esophageal cancer	0.000566	0.00497	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000564	0.00496	CcSEcCtD
Atazanavir—Nasopharyngitis—Cisplatin—esophageal cancer	0.00056	0.00492	CcSEcCtD
Atazanavir—Proteinuria—Methotrexate—esophageal cancer	0.000539	0.00474	CcSEcCtD
Atazanavir—Sleep disorder—Capecitabine—esophageal cancer	0.000534	0.00469	CcSEcCtD
Atazanavir—Protein urine present—Methotrexate—esophageal cancer	0.000532	0.00467	CcSEcCtD
Atazanavir—Diabetes mellitus—Capecitabine—esophageal cancer	0.000531	0.00466	CcSEcCtD
Atazanavir—Pancreatitis—Cisplatin—esophageal cancer	0.000531	0.00466	CcSEcCtD
Atazanavir—Photosensitivity—Capecitabine—esophageal cancer	0.000526	0.00462	CcSEcCtD
Atazanavir—Polyuria—Capecitabine—esophageal cancer	0.000526	0.00462	CcSEcCtD
Atazanavir—Saquinavir—ABCB1—esophageal cancer	0.000522	0.0981	CrCbGaD
Atazanavir—Gastroenteritis—Capecitabine—esophageal cancer	0.000521	0.00458	CcSEcCtD
Atazanavir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000521	0.00458	CcSEcCtD
Atazanavir—Vascular purpura—Capecitabine—esophageal cancer	0.000516	0.00454	CcSEcCtD
Atazanavir—Oliguria—Methotrexate—esophageal cancer	0.000514	0.00451	CcSEcCtD
Atazanavir—Libido decreased—Capecitabine—esophageal cancer	0.000498	0.00438	CcSEcCtD
Atazanavir—Increased appetite—Capecitabine—esophageal cancer	0.000492	0.00432	CcSEcCtD
Atazanavir—Amnesia—Capecitabine—esophageal cancer	0.000492	0.00432	CcSEcCtD
Atazanavir—Inflammation—Methotrexate—esophageal cancer	0.000488	0.00429	CcSEcCtD
Atazanavir—Dermatitis bullous—Capecitabine—esophageal cancer	0.000483	0.00425	CcSEcCtD
Atazanavir—Purpura—Capecitabine—esophageal cancer	0.000479	0.00421	CcSEcCtD
Atazanavir—Renal failure—Cisplatin—esophageal cancer	0.000475	0.00417	CcSEcCtD
Atazanavir—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000473	0.00416	CcSEcCtD
Atazanavir—Stomatitis—Cisplatin—esophageal cancer	0.000471	0.00413	CcSEcCtD
Atazanavir—Pain in extremity—Capecitabine—esophageal cancer	0.000462	0.00406	CcSEcCtD
Atazanavir—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000458	0.00403	CcSEcCtD
Atazanavir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000457	0.00401	CcSEcCtD
Atazanavir—Cardiac arrest—Capecitabine—esophageal cancer	0.000439	0.00386	CcSEcCtD
Atazanavir—Mood swings—Capecitabine—esophageal cancer	0.000438	0.00384	CcSEcCtD
Atazanavir—Dehydration—Capecitabine—esophageal cancer	0.00043	0.00377	CcSEcCtD
Atazanavir—Ecchymosis—Methotrexate—esophageal cancer	0.000428	0.00376	CcSEcCtD
Atazanavir—Urine output increased—Methotrexate—esophageal cancer	0.000428	0.00376	CcSEcCtD
Atazanavir—Mouth ulceration—Methotrexate—esophageal cancer	0.000428	0.00376	CcSEcCtD
Atazanavir—Urinary tract disorder—Cisplatin—esophageal cancer	0.000428	0.00376	CcSEcCtD
Atazanavir—Connective tissue disorder—Cisplatin—esophageal cancer	0.000426	0.00374	CcSEcCtD
Atazanavir—Urethral disorder—Cisplatin—esophageal cancer	0.000425	0.00373	CcSEcCtD
Atazanavir—Gynaecomastia—Methotrexate—esophageal cancer	0.000424	0.00372	CcSEcCtD
Atazanavir—Dry skin—Capecitabine—esophageal cancer	0.000423	0.00372	CcSEcCtD
Atazanavir—Breast disorder—Capecitabine—esophageal cancer	0.000417	0.00367	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000416	0.00365	CcSEcCtD
Atazanavir—Nasopharyngitis—Capecitabine—esophageal cancer	0.000413	0.00363	CcSEcCtD
Atazanavir—Gastritis—Capecitabine—esophageal cancer	0.000409	0.00359	CcSEcCtD
Atazanavir—Muscular weakness—Capecitabine—esophageal cancer	0.000407	0.00358	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000407	0.00358	CcSEcCtD
Atazanavir—Eye disorder—Cisplatin—esophageal cancer	0.000405	0.00356	CcSEcCtD
Atazanavir—Tinnitus—Cisplatin—esophageal cancer	0.000404	0.00355	CcSEcCtD
Atazanavir—Cardiac disorder—Cisplatin—esophageal cancer	0.000402	0.00353	CcSEcCtD
Atazanavir—Abdominal distension—Capecitabine—esophageal cancer	0.000402	0.00353	CcSEcCtD
Atazanavir—Diabetes mellitus—Methotrexate—esophageal cancer	0.000395	0.00347	CcSEcCtD
Atazanavir—Photosensitivity—Methotrexate—esophageal cancer	0.000392	0.00344	CcSEcCtD
Atazanavir—Polyuria—Methotrexate—esophageal cancer	0.000392	0.00344	CcSEcCtD
Atazanavir—Immune system disorder—Cisplatin—esophageal cancer	0.000392	0.00344	CcSEcCtD
Atazanavir—Mediastinal disorder—Cisplatin—esophageal cancer	0.000391	0.00343	CcSEcCtD
Atazanavir—Alopecia—Cisplatin—esophageal cancer	0.000383	0.00336	CcSEcCtD
Atazanavir—Malnutrition—Cisplatin—esophageal cancer	0.000377	0.00331	CcSEcCtD
Atazanavir—Neutropenia—Capecitabine—esophageal cancer	0.000373	0.00328	CcSEcCtD
Atazanavir—Flatulence—Cisplatin—esophageal cancer	0.000372	0.00327	CcSEcCtD
Atazanavir—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000364	0.0032	CcSEcCtD
Atazanavir—Weight increased—Capecitabine—esophageal cancer	0.000363	0.00319	CcSEcCtD
Atazanavir—Weight decreased—Capecitabine—esophageal cancer	0.000361	0.00317	CcSEcCtD
Atazanavir—Hyperglycaemia—Capecitabine—esophageal cancer	0.00036	0.00316	CcSEcCtD
Atazanavir—Depression—Capecitabine—esophageal cancer	0.000355	0.00312	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000353	0.0031	CcSEcCtD
Atazanavir—Ill-defined disorder—Cisplatin—esophageal cancer	0.00035	0.00308	CcSEcCtD
Atazanavir—Renal failure—Capecitabine—esophageal cancer	0.00035	0.00307	CcSEcCtD
Atazanavir—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000349	0.00306	CcSEcCtD
Atazanavir—Jaundice—Capecitabine—esophageal cancer	0.000347	0.00305	CcSEcCtD
Atazanavir—Stomatitis—Capecitabine—esophageal cancer	0.000347	0.00305	CcSEcCtD
Atazanavir—Urinary tract infection—Capecitabine—esophageal cancer	0.000346	0.00304	CcSEcCtD
Atazanavir—Malaise—Cisplatin—esophageal cancer	0.00034	0.00299	CcSEcCtD
Atazanavir—Haematuria—Capecitabine—esophageal cancer	0.000339	0.00298	CcSEcCtD
Atazanavir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000337	0.00296	CcSEcCtD
Atazanavir—Convulsion—Cisplatin—esophageal cancer	0.000327	0.00287	CcSEcCtD
Atazanavir—Mood swings—Methotrexate—esophageal cancer	0.000326	0.00286	CcSEcCtD
Atazanavir—Myalgia—Cisplatin—esophageal cancer	0.000321	0.00282	CcSEcCtD
Atazanavir—Anxiety—Cisplatin—esophageal cancer	0.00032	0.00281	CcSEcCtD
Atazanavir—Hepatitis—Capecitabine—esophageal cancer	0.00032	0.00281	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000319	0.0028	CcSEcCtD
Atazanavir—Hypoaesthesia—Capecitabine—esophageal cancer	0.000318	0.00279	CcSEcCtD
Atazanavir—Discomfort—Cisplatin—esophageal cancer	0.000317	0.00279	CcSEcCtD
Atazanavir—Urinary tract disorder—Capecitabine—esophageal cancer	0.000316	0.00277	CcSEcCtD
Atazanavir—Oedema peripheral—Capecitabine—esophageal cancer	0.000315	0.00276	CcSEcCtD
Atazanavir—Connective tissue disorder—Capecitabine—esophageal cancer	0.000314	0.00276	CcSEcCtD
Atazanavir—Urethral disorder—Capecitabine—esophageal cancer	0.000313	0.00275	CcSEcCtD
Atazanavir—Breast disorder—Methotrexate—esophageal cancer	0.000311	0.00273	CcSEcCtD
Atazanavir—Oedema—Cisplatin—esophageal cancer	0.000308	0.00271	CcSEcCtD
Atazanavir—Infection—Cisplatin—esophageal cancer	0.000306	0.00269	CcSEcCtD
Atazanavir—Erythema multiforme—Capecitabine—esophageal cancer	0.000302	0.00265	CcSEcCtD
Atazanavir—Nervous system disorder—Cisplatin—esophageal cancer	0.000302	0.00265	CcSEcCtD
Atazanavir—Skin disorder—Cisplatin—esophageal cancer	0.000299	0.00263	CcSEcCtD
Atazanavir—Eye disorder—Capecitabine—esophageal cancer	0.000299	0.00262	CcSEcCtD
Atazanavir—Tinnitus—Capecitabine—esophageal cancer	0.000298	0.00262	CcSEcCtD
Atazanavir—Hyperhidrosis—Cisplatin—esophageal cancer	0.000298	0.00262	CcSEcCtD
Atazanavir—Cardiac disorder—Capecitabine—esophageal cancer	0.000297	0.0026	CcSEcCtD
Atazanavir—Eosinophilia—Methotrexate—esophageal cancer	0.000294	0.00258	CcSEcCtD
Atazanavir—Anorexia—Cisplatin—esophageal cancer	0.000294	0.00258	CcSEcCtD
Atazanavir—Pancreatitis—Methotrexate—esophageal cancer	0.000291	0.00256	CcSEcCtD
Atazanavir—Angiopathy—Capecitabine—esophageal cancer	0.00029	0.00255	CcSEcCtD
Atazanavir—Immune system disorder—Capecitabine—esophageal cancer	0.000289	0.00254	CcSEcCtD
Atazanavir—Mediastinal disorder—Capecitabine—esophageal cancer	0.000288	0.00253	CcSEcCtD
Atazanavir—Alopecia—Capecitabine—esophageal cancer	0.000282	0.00248	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000281	0.00246	CcSEcCtD
Atazanavir—Mental disorder—Capecitabine—esophageal cancer	0.00028	0.00246	CcSEcCtD
Atazanavir—Malnutrition—Capecitabine—esophageal cancer	0.000278	0.00244	CcSEcCtD
Atazanavir—Neutropenia—Methotrexate—esophageal cancer	0.000278	0.00244	CcSEcCtD
Atazanavir—Dyspnoea—Cisplatin—esophageal cancer	0.000275	0.00241	CcSEcCtD
Atazanavir—Flatulence—Capecitabine—esophageal cancer	0.000274	0.00241	CcSEcCtD
Atazanavir—Erectile dysfunction—Methotrexate—esophageal cancer	0.000274	0.0024	CcSEcCtD
Atazanavir—Dysgeusia—Capecitabine—esophageal cancer	0.000272	0.00239	CcSEcCtD
Atazanavir—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000271	0.00238	CcSEcCtD
Atazanavir—Back pain—Capecitabine—esophageal cancer	0.000269	0.00236	CcSEcCtD
Atazanavir—Decreased appetite—Cisplatin—esophageal cancer	0.000268	0.00235	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000266	0.00234	CcSEcCtD
Atazanavir—Depression—Methotrexate—esophageal cancer	0.000264	0.00232	CcSEcCtD
Atazanavir—Pain—Cisplatin—esophageal cancer	0.000263	0.00231	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000263	0.00231	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—esophageal cancer	0.00026	0.00229	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—esophageal cancer	0.000258	0.00227	CcSEcCtD
Atazanavir—Ill-defined disorder—Capecitabine—esophageal cancer	0.000258	0.00227	CcSEcCtD
Atazanavir—Sweating—Methotrexate—esophageal cancer	0.000254	0.00223	CcSEcCtD
Atazanavir—Feeling abnormal—Cisplatin—esophageal cancer	0.000254	0.00223	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—esophageal cancer	0.000253	0.00222	CcSEcCtD
Atazanavir—Malaise—Capecitabine—esophageal cancer	0.000251	0.0022	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000251	0.0022	CcSEcCtD
Atazanavir—Syncope—Capecitabine—esophageal cancer	0.000249	0.00219	CcSEcCtD
Atazanavir—Palpitations—Capecitabine—esophageal cancer	0.000246	0.00216	CcSEcCtD
Atazanavir—Loss of consciousness—Capecitabine—esophageal cancer	0.000244	0.00215	CcSEcCtD
Atazanavir—Body temperature increased—Cisplatin—esophageal cancer	0.000243	0.00214	CcSEcCtD
Atazanavir—Cough—Capecitabine—esophageal cancer	0.000243	0.00213	CcSEcCtD
Atazanavir—Hypertension—Capecitabine—esophageal cancer	0.00024	0.00211	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—esophageal cancer	0.000238	0.00209	CcSEcCtD
Atazanavir—Chest pain—Capecitabine—esophageal cancer	0.000237	0.00208	CcSEcCtD
Atazanavir—Myalgia—Capecitabine—esophageal cancer	0.000237	0.00208	CcSEcCtD
Atazanavir—Arthralgia—Capecitabine—esophageal cancer	0.000237	0.00208	CcSEcCtD
Atazanavir—Anxiety—Capecitabine—esophageal cancer	0.000236	0.00207	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000235	0.00207	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—esophageal cancer	0.000235	0.00206	CcSEcCtD
Atazanavir—Discomfort—Capecitabine—esophageal cancer	0.000234	0.00206	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—esophageal cancer	0.000233	0.00205	CcSEcCtD
Atazanavir—Dry mouth—Capecitabine—esophageal cancer	0.000232	0.00203	CcSEcCtD
Atazanavir—Confusional state—Capecitabine—esophageal cancer	0.000229	0.00201	CcSEcCtD
Atazanavir—Oedema—Capecitabine—esophageal cancer	0.000227	0.00199	CcSEcCtD
Atazanavir—Hypersensitivity—Cisplatin—esophageal cancer	0.000227	0.00199	CcSEcCtD
Atazanavir—Infection—Capecitabine—esophageal cancer	0.000226	0.00198	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—esophageal cancer	0.000225	0.00198	CcSEcCtD
Atazanavir—Shock—Capecitabine—esophageal cancer	0.000223	0.00196	CcSEcCtD
Atazanavir—Nervous system disorder—Capecitabine—esophageal cancer	0.000223	0.00196	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—esophageal cancer	0.000222	0.00195	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—esophageal cancer	0.000222	0.00195	CcSEcCtD
Atazanavir—Asthenia—Cisplatin—esophageal cancer	0.000221	0.00194	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—esophageal cancer	0.000221	0.00194	CcSEcCtD
Atazanavir—Skin disorder—Capecitabine—esophageal cancer	0.000221	0.00194	CcSEcCtD
Atazanavir—Hyperhidrosis—Capecitabine—esophageal cancer	0.000219	0.00193	CcSEcCtD
Atazanavir—Anorexia—Capecitabine—esophageal cancer	0.000216	0.0019	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—esophageal cancer	0.000216	0.0019	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—esophageal cancer	0.000215	0.00189	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—esophageal cancer	0.000214	0.00188	CcSEcCtD
Atazanavir—Diarrhoea—Cisplatin—esophageal cancer	0.000211	0.00185	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—esophageal cancer	0.00021	0.00185	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—esophageal cancer	0.000208	0.00183	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—esophageal cancer	0.000207	0.00182	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000207	0.00182	CcSEcCtD
Atazanavir—Insomnia—Capecitabine—esophageal cancer	0.000205	0.0018	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—esophageal cancer	0.000203	0.00178	CcSEcCtD
Atazanavir—Dyspnoea—Capecitabine—esophageal cancer	0.000202	0.00178	CcSEcCtD
Atazanavir—Back pain—Methotrexate—esophageal cancer	0.0002	0.00176	CcSEcCtD
Atazanavir—Dyspepsia—Capecitabine—esophageal cancer	0.0002	0.00176	CcSEcCtD
Atazanavir—Decreased appetite—Capecitabine—esophageal cancer	0.000197	0.00173	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000196	0.00172	CcSEcCtD
Atazanavir—Vomiting—Cisplatin—esophageal cancer	0.000196	0.00172	CcSEcCtD
Atazanavir—Fatigue—Capecitabine—esophageal cancer	0.000196	0.00172	CcSEcCtD
Atazanavir—Rash—Cisplatin—esophageal cancer	0.000194	0.00171	CcSEcCtD
Atazanavir—Pain—Capecitabine—esophageal cancer	0.000194	0.00171	CcSEcCtD
Atazanavir—Constipation—Capecitabine—esophageal cancer	0.000194	0.00171	CcSEcCtD
Atazanavir—Dermatitis—Cisplatin—esophageal cancer	0.000194	0.0017	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—esophageal cancer	0.000192	0.00169	CcSEcCtD
Atazanavir—Feeling abnormal—Capecitabine—esophageal cancer	0.000187	0.00164	CcSEcCtD
Atazanavir—Malaise—Methotrexate—esophageal cancer	0.000187	0.00164	CcSEcCtD
Atazanavir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000186	0.00163	CcSEcCtD
Atazanavir—Nausea—Cisplatin—esophageal cancer	0.000183	0.00161	CcSEcCtD
Atazanavir—Cough—Methotrexate—esophageal cancer	0.000181	0.00159	CcSEcCtD
Atazanavir—Urticaria—Capecitabine—esophageal cancer	0.00018	0.00158	CcSEcCtD
Atazanavir—Abdominal pain—Capecitabine—esophageal cancer	0.000179	0.00158	CcSEcCtD
Atazanavir—Body temperature increased—Capecitabine—esophageal cancer	0.000179	0.00158	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—esophageal cancer	0.000179	0.00158	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—esophageal cancer	0.000176	0.00155	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—esophageal cancer	0.000176	0.00155	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—esophageal cancer	0.000176	0.00155	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000175	0.00154	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—esophageal cancer	0.000174	0.00153	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—esophageal cancer	0.00017	0.0015	CcSEcCtD
Atazanavir—Infection—Methotrexate—esophageal cancer	0.000168	0.00147	CcSEcCtD
Atazanavir—Hypersensitivity—Capecitabine—esophageal cancer	0.000167	0.00147	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—esophageal cancer	0.000166	0.00146	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—esophageal cancer	0.000164	0.00144	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—esophageal cancer	0.000163	0.00144	CcSEcCtD
Atazanavir—Asthenia—Capecitabine—esophageal cancer	0.000163	0.00143	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—esophageal cancer	0.000161	0.00141	CcSEcCtD
Atazanavir—Pruritus—Capecitabine—esophageal cancer	0.000161	0.00141	CcSEcCtD
Atazanavir—Diarrhoea—Capecitabine—esophageal cancer	0.000155	0.00136	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000154	0.00135	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—esophageal cancer	0.000153	0.00134	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—esophageal cancer	0.000151	0.00132	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—esophageal cancer	0.00015	0.00132	CcSEcCtD
Atazanavir—Dizziness—Capecitabine—esophageal cancer	0.00015	0.00132	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—esophageal cancer	0.000149	0.00131	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—esophageal cancer	0.000147	0.00129	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000146	0.00128	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—esophageal cancer	0.000146	0.00128	CcSEcCtD
Atazanavir—Pain—Methotrexate—esophageal cancer	0.000145	0.00127	CcSEcCtD
Atazanavir—Vomiting—Capecitabine—esophageal cancer	0.000144	0.00127	CcSEcCtD
Atazanavir—Rash—Capecitabine—esophageal cancer	0.000143	0.00126	CcSEcCtD
Atazanavir—Dermatitis—Capecitabine—esophageal cancer	0.000143	0.00126	CcSEcCtD
Atazanavir—Headache—Capecitabine—esophageal cancer	0.000142	0.00125	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—esophageal cancer	0.000139	0.00122	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000138	0.00121	CcSEcCtD
Atazanavir—Nausea—Capecitabine—esophageal cancer	0.000135	0.00118	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—esophageal cancer	0.000134	0.00118	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—esophageal cancer	0.000134	0.00117	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—esophageal cancer	0.000134	0.00117	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—esophageal cancer	0.000125	0.00109	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—esophageal cancer	0.000121	0.00107	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—esophageal cancer	0.00012	0.00105	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—esophageal cancer	0.000116	0.00102	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—esophageal cancer	0.000112	0.000982	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—esophageal cancer	0.000107	0.000944	CcSEcCtD
Atazanavir—Rash—Methotrexate—esophageal cancer	0.000107	0.000936	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—esophageal cancer	0.000106	0.000935	CcSEcCtD
Atazanavir—Headache—Methotrexate—esophageal cancer	0.000106	0.00093	CcSEcCtD
Atazanavir—Nausea—Methotrexate—esophageal cancer	0.0001	0.000882	CcSEcCtD
Atazanavir—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	7.88e-05	0.00122	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.86e-05	0.00122	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	7.78e-05	0.00121	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	7.77e-05	0.00121	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	7.74e-05	0.0012	CbGpPWpGaD
Atazanavir—ABCC1—Disease—WIF1—esophageal cancer	7.73e-05	0.0012	CbGpPWpGaD
Atazanavir—ABCC1—Disease—DOCK2—esophageal cancer	7.73e-05	0.0012	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TYMP—esophageal cancer	7.68e-05	0.00119	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC10A2—esophageal cancer	7.62e-05	0.00118	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CA1—esophageal cancer	7.62e-05	0.00118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	7.6e-05	0.00118	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.54e-05	0.00117	CbGpPWpGaD
Atazanavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	7.53e-05	0.00117	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP26A1—esophageal cancer	7.47e-05	0.00116	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	7.41e-05	0.00115	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	7.31e-05	0.00113	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALOX15—esophageal cancer	7.28e-05	0.00113	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	7.28e-05	0.00113	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CSNK1A1—esophageal cancer	7.14e-05	0.00111	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CA2—esophageal cancer	6.97e-05	0.00108	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—TPI1—esophageal cancer	6.94e-05	0.00108	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTO1—esophageal cancer	6.94e-05	0.00108	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	6.9e-05	0.00107	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	6.86e-05	0.00106	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.81e-05	0.00106	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	6.81e-05	0.00105	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALDOB—esophageal cancer	6.66e-05	0.00103	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	6.6e-05	0.00102	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	6.58e-05	0.00102	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	6.52e-05	0.00101	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PLCE1—esophageal cancer	6.48e-05	0.001	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH7—esophageal cancer	6.48e-05	0.001	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	6.45e-05	0.001	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GAPDH—esophageal cancer	6.41e-05	0.000993	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.4e-05	0.000993	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	6.39e-05	0.00099	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CRABP1—esophageal cancer	6.35e-05	0.000984	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	6.31e-05	0.000978	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	6.31e-05	0.000978	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.11e-05	0.000948	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.04e-05	0.000937	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GNG7—esophageal cancer	6.04e-05	0.000936	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ELMO1—esophageal cancer	6e-05	0.00093	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TPI1—esophageal cancer	5.86e-05	0.000909	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GSTO1—esophageal cancer	5.86e-05	0.000909	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADH1B—esophageal cancer	5.68e-05	0.00088	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALDH2—esophageal cancer	5.66e-05	0.000877	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ALDOB—esophageal cancer	5.62e-05	0.000871	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.56e-05	0.000861	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TYMP—esophageal cancer	5.43e-05	0.000841	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIST1H2BM—esophageal cancer	5.41e-05	0.000839	CbGpPWpGaD
Atazanavir—ABCC1—Disease—GAPDH—esophageal cancer	5.41e-05	0.000839	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTT1—esophageal cancer	5.38e-05	0.000835	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.33e-05	0.000827	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2A6—esophageal cancer	5.32e-05	0.000825	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.3e-05	0.000822	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP26A1—esophageal cancer	5.28e-05	0.000819	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.2e-05	0.000806	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALOX15—esophageal cancer	5.15e-05	0.000798	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.14e-05	0.000796	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.13e-05	0.000795	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ENO1—esophageal cancer	5.05e-05	0.000782	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS1—esophageal cancer	5.05e-05	0.000782	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.04e-05	0.000781	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PSME1—esophageal cancer	4.97e-05	0.000771	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PSME2—esophageal cancer	4.97e-05	0.000771	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTO1—esophageal cancer	4.91e-05	0.000761	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TPI1—esophageal cancer	4.91e-05	0.000761	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	4.89e-05	0.000758	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.82e-05	0.000747	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.78e-05	0.000741	CbGpPWpGaD
Atazanavir—ABCC1—Disease—XIAP—esophageal cancer	4.78e-05	0.000741	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALDOB—esophageal cancer	4.71e-05	0.00073	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GAPDH—esophageal cancer	4.53e-05	0.000702	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CRABP1—esophageal cancer	4.49e-05	0.000696	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.48e-05	0.000695	CbGpPWpGaD
Atazanavir—ABCC1—Disease—B2M—esophageal cancer	4.44e-05	0.000689	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.34e-05	0.000673	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	4.34e-05	0.000672	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP1B1—esophageal cancer	4.29e-05	0.000665	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.29e-05	0.000665	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GNG7—esophageal cancer	4.27e-05	0.000662	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.27e-05	0.000662	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC52A3—esophageal cancer	4.26e-05	0.000661	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BLVRB—esophageal cancer	4.26e-05	0.000661	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ENO1—esophageal cancer	4.26e-05	0.00066	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PSME1—esophageal cancer	4.2e-05	0.000651	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PSME2—esophageal cancer	4.2e-05	0.000651	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP19A1—esophageal cancer	4.03e-05	0.000625	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CALR—esophageal cancer	4.03e-05	0.000624	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALDH2—esophageal cancer	4e-05	0.00062	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.98e-05	0.000617	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.98e-05	0.000617	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FBXW7—esophageal cancer	3.9e-05	0.000604	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTT1—esophageal cancer	3.81e-05	0.00059	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2A6—esophageal cancer	3.76e-05	0.000583	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.75e-05	0.000581	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.68e-05	0.000571	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—HMOX1—esophageal cancer	3.68e-05	0.000571	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.62e-05	0.000562	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA1—esophageal cancer	3.62e-05	0.000562	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.61e-05	0.00056	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.58e-05	0.000554	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS1—esophageal cancer	3.57e-05	0.000553	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ENO1—esophageal cancer	3.57e-05	0.000553	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.56e-05	0.000552	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.56e-05	0.000552	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ABCB1—esophageal cancer	3.53e-05	0.000548	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PSME1—esophageal cancer	3.51e-05	0.000545	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PSME2—esophageal cancer	3.51e-05	0.000545	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3.5e-05	0.000542	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA1—esophageal cancer	3.39e-05	0.000525	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.39e-05	0.000525	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CA2—esophageal cancer	3.31e-05	0.000514	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.16e-05	0.00049	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFBR2—esophageal cancer	3.15e-05	0.000488	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CA2—esophageal cancer	3.1e-05	0.00048	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH7—esophageal cancer	3.08e-05	0.000478	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLCE1—esophageal cancer	3.08e-05	0.000478	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.07e-05	0.000476	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.06e-05	0.000474	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1B1—esophageal cancer	3.03e-05	0.00047	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.03e-05	0.000469	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SMAD4—esophageal cancer	2.98e-05	0.000462	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.91e-05	0.000451	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH7—esophageal cancer	2.88e-05	0.000446	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.88e-05	0.000446	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP19A1—esophageal cancer	2.85e-05	0.000442	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.85e-05	0.000441	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADH1B—esophageal cancer	2.7e-05	0.000419	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.67e-05	0.000414	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.64e-05	0.00041	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.63e-05	0.000407	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.63e-05	0.000407	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—HMOX1—esophageal cancer	2.6e-05	0.000403	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TYMP—esophageal cancer	2.58e-05	0.0004	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.55e-05	0.000396	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.53e-05	0.000393	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.52e-05	0.000391	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.51e-05	0.000389	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—esophageal cancer	2.5e-05	0.000387	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.48e-05	0.000384	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALOX15—esophageal cancer	2.45e-05	0.00038	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—esophageal cancer	2.44e-05	0.000378	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TYMP—esophageal cancer	2.41e-05	0.000374	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CREBBP—esophageal cancer	2.36e-05	0.000366	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.35e-05	0.000364	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTO1—esophageal cancer	2.34e-05	0.000362	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TPI1—esophageal cancer	2.34e-05	0.000362	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.29e-05	0.000355	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOB—esophageal cancer	2.24e-05	0.000347	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.23e-05	0.000346	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA1—esophageal cancer	2.23e-05	0.000346	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—esophageal cancer	2.22e-05	0.000344	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOTCH1—esophageal cancer	2.2e-05	0.000341	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.18e-05	0.000338	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TPI1—esophageal cancer	2.18e-05	0.000338	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GAPDH—esophageal cancer	2.16e-05	0.000334	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.15e-05	0.000333	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CRABP1—esophageal cancer	2.14e-05	0.000331	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NOS3—esophageal cancer	2.11e-05	0.000328	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.09e-05	0.000324	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.08e-05	0.000323	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA2—esophageal cancer	2.04e-05	0.000317	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNG7—esophageal cancer	2.03e-05	0.000315	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.01e-05	0.000312	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CRABP1—esophageal cancer	2e-05	0.000309	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CREBBP—esophageal cancer	1.99e-05	0.000309	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—esophageal cancer	1.93e-05	0.0003	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDH2—esophageal cancer	1.9e-05	0.000295	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.9e-05	0.000294	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH7—esophageal cancer	1.9e-05	0.000294	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNG7—esophageal cancer	1.9e-05	0.000294	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.89e-05	0.000293	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—esophageal cancer	1.81e-05	0.000281	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.79e-05	0.000277	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS3—esophageal cancer	1.78e-05	0.000277	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.78e-05	0.000276	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ENO1—esophageal cancer	1.7e-05	0.000263	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS1—esophageal cancer	1.7e-05	0.000263	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.7e-05	0.000263	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.69e-05	0.000262	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.67e-05	0.000259	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSME2—esophageal cancer	1.67e-05	0.000259	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSME1—esophageal cancer	1.67e-05	0.000259	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CREBBP—esophageal cancer	1.67e-05	0.000259	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—esophageal cancer	1.67e-05	0.000259	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.67e-05	0.000258	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.66e-05	0.000258	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—esophageal cancer	1.63e-05	0.000253	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—EP300—esophageal cancer	1.61e-05	0.000249	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TYMP—esophageal cancer	1.59e-05	0.000247	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.59e-05	0.000246	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ENO1—esophageal cancer	1.59e-05	0.000246	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSME1—esophageal cancer	1.56e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSME2—esophageal cancer	1.56e-05	0.000242	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.55e-05	0.00024	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.51e-05	0.000234	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NOS3—esophageal cancer	1.49e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.44e-05	0.000224	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.44e-05	0.000223	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TPI1—esophageal cancer	1.44e-05	0.000223	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—esophageal cancer	1.43e-05	0.000221	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.38e-05	0.000214	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—esophageal cancer	1.37e-05	0.000212	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.36e-05	0.000211	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EP300—esophageal cancer	1.36e-05	0.00021	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.36e-05	0.00021	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.35e-05	0.000209	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.33e-05	0.000206	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.32e-05	0.000204	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.27e-05	0.000196	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNG7—esophageal cancer	1.25e-05	0.000194	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—esophageal cancer	1.24e-05	0.000192	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	1.19e-05	0.000184	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—esophageal cancer	1.18e-05	0.000183	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.17e-05	0.000182	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—esophageal cancer	1.16e-05	0.000179	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.16e-05	0.000179	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—EP300—esophageal cancer	1.14e-05	0.000176	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.13e-05	0.000176	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.12e-05	0.000173	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.11e-05	0.000172	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.1e-05	0.000171	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.05e-05	0.000162	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENO1—esophageal cancer	1.05e-05	0.000162	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSME2—esophageal cancer	1.03e-05	0.00016	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSME1—esophageal cancer	1.03e-05	0.00016	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—esophageal cancer	1e-05	0.000156	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.89e-06	0.000138	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—esophageal cancer	8.41e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.39e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.36e-06	0.00013	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CREBBP—esophageal cancer	7.94e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.63e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CREBBP—esophageal cancer	7.42e-06	0.000115	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.32e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NOS3—esophageal cancer	7.11e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NOS3—esophageal cancer	6.64e-06	0.000103	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—esophageal cancer	6.5e-06	0.000101	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.08e-06	9.42e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—EP300—esophageal cancer	5.41e-06	8.38e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EP300—esophageal cancer	5.05e-06	7.83e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.89e-06	7.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NOS3—esophageal cancer	4.38e-06	6.79e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.01e-06	6.21e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—esophageal cancer	4e-06	6.2e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.74e-06	5.79e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EP300—esophageal cancer	3.33e-06	5.17e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.46e-06	3.82e-05	CbGpPWpGaD
